Literature DB >> 11196110

Neuroleptic malignant syndrome in a patient with citrullinaemia.

A Dursun1, Y Yilma, M Ozsari, N Kandemir, T Coşkun.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11196110     DOI: 10.1023/a:1026716820324

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


× No keyword cloud information.
  5 in total

Review 1.  Sympathoadrenal hyperactivity and the etiology of neuroleptic malignant syndrome.

Authors:  R J Gurrera
Journal:  Am J Psychiatry       Date:  1999-02       Impact factor: 18.112

2.  Navigating neuroleptic malignant syndrome.

Authors:  C Cahill; G W Arana
Journal:  Am J Nurs       Date:  1986-06       Impact factor: 2.220

3.  Neuroleptic malignant syndrome: review and analysis of 115 cases.

Authors:  G Addonizio; V L Susman; S D Roth
Journal:  Biol Psychiatry       Date:  1987-08       Impact factor: 13.382

Review 4.  Neuroleptic malignant syndrome.

Authors:  J L Levenson
Journal:  Am J Psychiatry       Date:  1985-10       Impact factor: 18.112

Review 5.  Neuroleptic malignant syndrome in children and adolescents.

Authors:  R R Silva; D M Munoz; M Alpert; I R Perlmutter; J Diaz
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  1999-02       Impact factor: 8.829

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.